Details for New Drug Application (NDA): 206352
✉ Email this page to a colleague
The generic ingredient in REYATAZ is atazanavir sulfate. There are twenty-five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the atazanavir sulfate profile page.
Summary for 206352
Tradename: | REYATAZ |
Applicant: | Bristol Myers Squibb |
Ingredient: | atazanavir sulfate |
Patents: | 0 |
Suppliers and Packaging for NDA: 206352
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
REYATAZ | atazanavir sulfate | POWDER;ORAL | 206352 | NDA | E.R. Squibb & Sons, L.L.C. | 0003-3638 | 0003-3638-10 | 30 PACKET in 1 CARTON (0003-3638-10) / 1 POWDER in 1 PACKET |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | EQ 50MG BASE/PACKET | ||||
Approval Date: | Jun 2, 2014 | TE: | RLD: | Yes |
Expired US Patents for NDA 206352
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | REYATAZ | atazanavir sulfate | POWDER;ORAL | 206352-001 | Jun 2, 2014 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | REYATAZ | atazanavir sulfate | POWDER;ORAL | 206352-001 | Jun 2, 2014 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription